Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass

Authors:

Abstract
Factors underlying variable weight loss (WL) after Roux-en-Y Gastric Bypass (RYGB) are poorly understood. To gain insight on the role of gastrointestinal hormones on poor-WL maintenance (P-WLM) following RYGB. First, GLP-1, PYY, and ghrelin responses to a standardized mixed liquid meal (SMLM) were compared between subjects with good-WL (G-WL, n=32) or P-WLM (n=22). Second, we evaluated food intake (FI) following blockade of gut hormonal secretion in G-WL (n=23) or P-WLM (n=19) subjects. Finally, the impact of dietary-induced WL on the hormonal response in subjects with P-WLM (n=14) was assessed. Tertiary hospital. Studies 1 and 3: area under the curve of gut hormones following a SMLM. Study 2: FI following subcutaneous injection of saline or octreotide. P-WLM associated a blunted GLP-1 (p=0.044) and PYY (p=0.001) responses and lesser suppression of ghrelin (p=0.032) following the SMLM challenge. On saline-day, FI in the G-WL (393±143 kcal) group was less than in the P-WLM (519±143 Kcal; p=0.014) group. Octreotide injection resulted in enlarged FI in both groups (G-WL: 579±248 kcal, p=0.014; P-WLM: 798±284 Kcal, p=0.036) but the difference in FI between groups remained (p<0.001). In subjects with P-WLM, dietary-induced WL resulted in larger ghrelin suppression (p=0.046) but no change in the GLP-1 or PYY responses. Our data show gastrointestinal hormones play a role in the control of FI following RYGB, but do not support changes in GLP-1, PYY, or ghrelin play a major role as determinants of P-WLM after this type of surgery.

This publication has 31 references indexed in Scilit: